Filter by: patients
Home > Community Treatment Reports and Side Effects > Fondaparinux Treatment Report
What is Fondaparinux?

Fondaparinux is a Factor Xa Inhibitor that is used to prevent deep vein thrombosis (DVT) in patients undergoing hip replacement, knee replacement, hip fracture, or abdominal surgery; treatment of acute pulmonary embolism (PE).

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
anti coagulant 2 1 Efficacy_cant_tell
Prevent blood clotting 1 0
Pulmonary Embolism 1 0
Factor V Leiden 1 0

See all 3 patients currently taking Fondaparinux

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  2.5 mg/0.5 mL daily 5 mg/0.4 mL daily 10 mg/0.8 mL daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Fondaparinux (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 100%
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Fondaparinux

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Fondaparinux

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Fondaparinux

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Fondaparinux

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Fondaparinux

Very
 0 0%
Somewhat
 1 100%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Fondaparinux

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.